Non-small cell lung cancer. [J Natl Compr Canc Netw. 2010] - PubMed

loading

Practice guidelines for non-small cell lung cancer. [Cancer J Sci Am. 1996]
Practice guidelines for non-small cell lung cancer.
Cameron R, Fringer J, Taylor C, Gilden CR, Figlin RA. Cancer J Sci Am. 1996 May-Jun; 2(3A Suppl):S61-8.
Review [Non-small cell lung cancer]. [Ryoikibetsu Shokogun Shirizu. ...]
Review [Non-small cell lung cancer].
Yoshimura A, Niitani H. Ryoikibetsu Shokogun Shirizu. 1994; (4):100-3.
Non-small cell lung cancer. [J Natl Compr Canc Netw. 2012]
Non-small cell lung cancer.
Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, et al. J Natl Compr Canc Netw. 2012 Oct 1; 10(10):1236-71.
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement. [Clin Cancer Res. 2005]
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
Lynch TJ, Bogart JA, Curran WJ Jr, DeCamp MM, Gandara DR, Goss G, Henschke CI, Jett JR, Johnson BE, Kelly KL, et al. Clin Cancer Res. 2005 Jul 1; 11(13 Pt 2):4981s-4983s.
Review [Association of molecular biology of lung cancers and their metastasis and prognosis]. [Zhonghua Zhong Liu Za Zhi. 2006]
Review [Association of molecular biology of lung cancers and their metastasis and prognosis].
Mao YS, Gao YN, He J. Zhonghua Zhong Liu Za Zhi. 2006 Aug; 28(8):632-4.

Bronchial anthracofibrosis and macroscopic tissue pigmentation on EBUS-TBNA predict a low probability of metastatic lymphadenopathy in Korean lung cancer patients. [J Korean Med Sci. 2013]
Bronchial anthracofibrosis and macroscopic tissue pigmentation on EBUS-TBNA predict a low probability of metastatic lymphadenopathy in Korean lung cancer patients.
Kim MA, Lee JC, Choi CM. J Korean Med Sci. 2013 Mar; 28(3):383-7. Epub 2013 Mar 4.
Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy. [PLoS One. 2013]
Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy.
Chen YC, Hsiao CC, Chen KD, Hung YC, Wu CY, Lie CH, Liu SF, Sung MT, Chen CJ, Wang TY, et al. PLoS One. 2013; 8(2):e57053. Epub 2013 Feb 25.
EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation. [Int J Med Sci. 2013]
EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation.
Antonicelli A, Cafarotti S, Indini A, Galli A, Russo A, Cesario A, Lococo FM, Russo P, Mainini AF, Bonifati LG, et al. Int J Med Sci. 2013; 10(3):320-30. Epub 2013 Feb 11.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Non-small cell lung cancer.
Non-small cell lung cancer.
J Natl Compr Canc Netw. 2010 Jul ;8(7):740-801.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed